These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 31257852

  • 1. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
    Falcucci RM, Wertz R, Green JL, Meucci O, Salvino J, Fontana ACK.
    ACS Chem Neurosci; 2019 Aug 21; 10(8):3437-3453. PubMed ID: 31257852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.
    Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB.
    J Cell Physiol; 2011 Oct 21; 226(10):2484-93. PubMed ID: 21792905
    [Abstract] [Full Text] [Related]

  • 5. Current approaches to enhance glutamate transporter function and expression.
    Fontana AC.
    J Neurochem; 2015 Sep 21; 134(6):982-1007. PubMed ID: 26096891
    [Abstract] [Full Text] [Related]

  • 6. Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays.
    van Veggel L, Mocking TAM, Sijben HJ, Liu R, Gorostiola González M, Dilweg MA, Royakkers J, Li A, Kumar V, Dong YY, Bullock A, Sauer DB, Diliën H, van Westen GJP, Schreiber R, Heitman LH, Vanmierlo T.
    ACS Chem Neurosci; 2024 Apr 03; 15(7):1424-1431. PubMed ID: 38478848
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.
    Green JL, Dos Santos WF, Fontana ACK.
    Biochem Pharmacol; 2021 Nov 03; 193():114786. PubMed ID: 34571003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains.
    Mortensen OV, Liberato JL, Coutinho-Netto J, Dos Santos WF, Fontana AC.
    J Neurochem; 2015 Apr 03; 133(2):199-210. PubMed ID: 25626691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA.
    J Cereb Blood Flow Metab; 2007 Jul 03; 27(7):1327-38. PubMed ID: 17213861
    [Abstract] [Full Text] [Related]

  • 14. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke.
    Hurtado O, Pradillo JM, Fernández-López D, Morales JR, Sobrino T, Castillo J, Alborch E, Moro MA, Lizasoain I.
    Neurobiol Dis; 2008 Jan 03; 29(1):123-31. PubMed ID: 17884513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targets of cytoprotection in acute ischemic stroke: present and future.
    Lizasoain I, Cárdenas A, Hurtado O, Romera C, Mallolas J, Lorenzo P, Castillo J, Moro MA.
    Cerebrovasc Dis; 2006 Jan 03; 21 Suppl 2():1-8. PubMed ID: 16651809
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I.
    Neurobiol Dis; 2005 Mar 03; 18(2):336-45. PubMed ID: 15686962
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer's disease.
    Manisha C, Selvaraj A, Jubie S, Moola Joghee Nanjan C, Moola Joghee N, Clement JP, Justin A.
    Med Hypotheses; 2020 Sep 03; 142():109794. PubMed ID: 32413698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.